Cantharidins Induce ER Stress and a Terminal Unfolded Protein Response in OSCC

Mortality and morbidity associated with oral squamous cell carcinoma (OSCC) remain unacceptably high with disfiguring treatment options and a death rate of 1 per hour in the United States. The approval of cituximab for advanced OSCC has been the only new treatment for these patients since the 1970s,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Dent Res
Main Authors: Xi, Y., Garshott, D.M., Brownell, A.L., Yoo, G.H., Lin, H.-S., Freeburg, T.L., Yoo, N.G., Kaufman, R.J., Callaghan, M.U., Fribley, A.M.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2015
Assuntos:
Research Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4300301/
https://ncbi.nlm.nih.gov/pubmed/25425581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0022034514559376
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados